SECURA BIO, INC

Secura Bio, Inc. specializes in the manufacturing of pharmaceutical preparations, with demonstrated expertise in the production of drugs, hematological agents, and related therapeutics for federal healthcare applications. The company operates under NAICS 325412, focusing on the formulation, packaging, and quality-controlled production of finished dosage forms compliant with FDA and federal supply schedule requirements. Their technical capabilities include aseptic processing, batch validation, stability testing, and adherence to cGMP standards to ensure consistent product integrity for clinical use. As a small business operating under the 2L entity structure, Secura Bio emphasizes precision manufacturing processes tailored to the stringent regulatory demands of government health programs. The company has established a direct working relationship with the Department of Veterans Affairs, supplying pharmaceutical products under the Federal Supply Schedule for use in VA medical facilities. This engagement reflects a focused alignment with VA’s mission to deliver reliable, accessible medications to veteran populations, particularly in areas such as chronic disease management and hematological therapeutics. The nature of the award suggests consistent compliance with federal procurement protocols and supply chain reliability for mission-critical pharmaceuticals. Secura Bio’s industry focus is narrowly centered on pharmaceutical preparation manufacturing, positioning them as a specialized supplier within the federal healthcare supply chain. Their market presence is defined by the production of high-integrity, regulated drug products rather than broad-scale drug development or distribution. This vertical specialization enables them to serve as a trusted source for standardized, FDA-validated pharmaceuticals required by federal medical providers. Located in Las Vegas, Nevada, Secura Bio, Inc. is a small business entity without federal certifications such as 8(a), HUBZone, or WOSB. Their geographic footprint is limited to their operational base, but their government market positioning is anchored in direct supply to VA healthcare systems through established procurement channels.